Lignocaine kinetics in the rat
Authors:
- 1 April 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 36 (4) , 240-243
Abstract
After intravenous injection of lignocaine 2·5, 5·0 or 10·0 mg kg−1 in the rat blood concentration declined in a bi-exponential manner. The data were analysed according to a two-compartment open model with elimination from the central compartment. Analysis of variance revealed no significant differences in k12, k21, k13, t1/2α, t1/2β, AUC or in the volume constants for the different doses used. After lignocaine 50·0, 70·0 or 90·0 mg kg−1 by mouth there was no significant change in t1/2β for the different doses or in peak plasma concentration normalized for dose. For both routes of administration blood concentration-time curves were superimposible and AUC was linearly related to dose. Renal excretion was negligible. Systemic availability of lignocaine was the lowest of species so far studied (mean 0·019 ± 0·001) did not alter with dose, and was very similar to the values in the literature quoted for the isolated perfused liver. Clearance of lignocaine related to anticipated liver mass was almost identical to the values for liver blood flow quoted using other techniques. The data indicated high hepatic extraction of lignocaine by the intact rat and the absence of dose dependency within the range studied.Keywords
This publication has 16 references indexed in Scilit:
- Pharmacokinetics of lidocaine and its deethylated metabolite: Dose and time dependency studies in manJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.British Journal of Clinical Pharmacology, 1979
- Effects of phenobarbitone on hepatic microsomal enzyme activity and liver blood flow in spontaneously hypertensive ratsLife Sciences, 1979
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Effect of hepatic nerve stimulation on hepatic uptake of lidocaine in the catLife Sciences, 1976
- Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion modelClinical Pharmacology & Therapeutics, 1974
- Meperidine and Other Basic Drugs: General Method for Their Determination in PlasmaJournal of Pharmaceutical Sciences, 1974
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973
- Pharmacokinetics of lidocaine in manClinical Pharmacology & Therapeutics, 1971
- The Distribution of 14C-Labelled Lidocaine Injected Intravenously in the RatAnesthesiology, 1968